rs4143022

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002101.5(GYPC):​c.49+8150A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 152,160 control chromosomes in the GnomAD database, including 1,454 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1454 hom., cov: 32)

Consequence

GYPC
NM_002101.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.103

Publications

3 publications found
Variant links:
Genes affected
GYPC (HGNC:4704): (glycophorin C (Gerbich blood group)) Glycophorin C (GYPC) is an integral membrane glycoprotein. It is a minor species carried by human erythrocytes, but plays an important role in regulating the mechanical stability of red cells. A number of glycophorin C mutations have been described. The Gerbich and Yus phenotypes are due to deletion of exon 3 and 2, respectively. The Webb and Duch antigens, also known as glycophorin D, result from single point mutations of the glycophorin C gene. The glycophorin C protein has very little homology with glycophorins A and B. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
GYPC Gene-Disease associations (from GenCC):
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002101.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.392 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002101.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GYPC
NM_002101.5
MANE Select
c.49+8150A>G
intron
N/ANP_002092.1P04921-1
GYPC
NM_016815.4
c.49+8150A>G
intron
N/ANP_058131.1P04921-3
GYPC
NM_001256584.2
c.-833+8150A>G
intron
N/ANP_001243513.1P04921-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GYPC
ENST00000259254.9
TSL:1 MANE Select
c.49+8150A>G
intron
N/AENSP00000259254.4P04921-1
GYPC
ENST00000409836.3
TSL:1
c.49+8150A>G
intron
N/AENSP00000386904.3P04921-3
GYPC
ENST00000356887.12
TSL:1
c.-833+8150A>G
intron
N/AENSP00000349354.7P04921-2

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16375
AN:
152042
Hom.:
1446
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0220
Gnomad AMI
AF:
0.176
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.0681
Gnomad EAS
AF:
0.405
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.110
Gnomad OTH
AF:
0.101
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.108
AC:
16407
AN:
152160
Hom.:
1454
Cov.:
32
AF XY:
0.114
AC XY:
8446
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0220
AC:
912
AN:
41534
American (AMR)
AF:
0.217
AC:
3326
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0681
AC:
236
AN:
3468
East Asian (EAS)
AF:
0.406
AC:
2092
AN:
5152
South Asian (SAS)
AF:
0.158
AC:
759
AN:
4798
European-Finnish (FIN)
AF:
0.115
AC:
1217
AN:
10596
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.110
AC:
7477
AN:
68000
Other (OTH)
AF:
0.105
AC:
222
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
699
1398
2098
2797
3496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
1035
Bravo
AF:
0.113
Asia WGS
AF:
0.242
AC:
840
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.2
DANN
Benign
0.46
PhyloP100
-0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4143022;
hg19: chr2-127422038;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.